Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study.
about
Targeted radioimmunotherapy: the role of ¹³¹I-chTNT-1/B mAb (Cotara) for treatment of high-grade gliomas.PET Imaging in Patients with Meningioma - Report of the RANO/PET Group.Somatostatin receptor subtype 2 in high-grade gliomas: PET/CT with (68)Ga-DOTA-peptides, correlation to prognostic markers, and implications for targeted radiotherapyTargeted radiotherapy of brain tumours.Receptor-mediated tumor targeting with radiopeptides. Part 1. General concepts and methods: applications to somatostatin receptor-expressing tumors.Genomic biomarkers for molecular imaging: predicting the futureSomatostatin receptor 2A in gliomas: Association with oligodendrogliomas and favourable outcome.Feasibility of experimental BT4C glioma models for somatostatin receptor 2-targeted therapies.Three-year recurrence-free survival in a patient with recurrent medulloblastoma after resection, high-dose chemotherapy, and intrathecal Yttrium-90-labeled DOTA0-D-Phe1-Tyr3-octreotide radiopeptide brachytherapy.111In-pentetreotide scintigraphy in medulloblastoma: a comparison with magnetic resonance imaging.Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with 213Bi-substance P analogue.Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcomeSomatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome
P2860
Q34286194-21BD8BBF-4338-4755-A927-17B2A5ACC53DQ34682187-E5DFFE95-E41F-48E9-BA9C-B93299350DA6Q35572487-F61E9C6D-A203-4B7B-847C-2DB43544B12BQ35745251-1494E805-2CCB-40B4-AF81-02716779AFDAQ36008285-27F0408A-93C2-4D39-A5F1-C18AD54B197BQ37508283-2FFCF32E-FF4F-4EC5-89A1-545B516685C2Q38806908-B63319CE-89B3-4475-B0F8-D721833D8733Q38981899-012DADB8-E6A2-45CA-9EBA-44F6403EE9A0Q45217484-62C4006C-F7A8-4408-BD44-5E689C0C5018Q48200381-B3DCB9AA-5A65-420A-86DA-E8E75B0526E5Q52715248-D41AFB18-04D1-4C32-93AC-2E4C05BD1AEDQ57447437-E1AB73DF-A0DF-46C5-9AAD-37204D0B16C9Q58760293-0633E2F8-31F9-47C4-9BCA-F1578E7B5208
P2860
Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Local injection of the 90Y-lab ...... III: an extended pilot study.
@ast
Local injection of the 90Y-lab ...... III: an extended pilot study.
@en
Local injection of the 90Y-lab ...... III: an extended pilot study.
@nl
type
label
Local injection of the 90Y-lab ...... III: an extended pilot study.
@ast
Local injection of the 90Y-lab ...... III: an extended pilot study.
@en
Local injection of the 90Y-lab ...... III: an extended pilot study.
@nl
prefLabel
Local injection of the 90Y-lab ...... III: an extended pilot study.
@ast
Local injection of the 90Y-lab ...... III: an extended pilot study.
@en
Local injection of the 90Y-lab ...... III: an extended pilot study.
@nl
P2093
P1476
Local injection of the 90Y-lab ...... III: an extended pilot study.
@en
P2093
Eichhorn K
Mueller-Brand J
Schumacher T
P2888
P304
P356
10.1007/S00259-001-0717-X
P577
2002-01-29T00:00:00Z